RECENT NEWS

Roche has said that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for mpox, formerly known as monkeypox.

Digital pathology and AI firm Paige has announed the launch of OmniScreen, a pioneering AI-driven biomarker module capable of evaluating over 505 genes and detecting 1,228 molecular biomarkers from routine H&E-stained digital pathology slides.

Visitor registration for Lab Innovations 2024 is now live. The UK’s largest annual exhibition for the whole laboratory industry will take place at the NEC, Birmingham, on 30-31 October, featuring engaging talks and exhibitors that will showcase innovation and champion sustainability.

Pathology services provider Synnovis has recently confirmed it has rebuilt its core IT systems following the cyberattack on 3 June. It has now resumed testing services for GPs in Bexley, Lewisham and Greenwich, three of the six boroughs it serves.

A new study has found that most routine laboratory tests are not reliable for diagnosing Long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).

WHO Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations.

The Royal College of Pathologists (RCPath) has submitted evidence to Lord Darzi's review of the NHS outlining the challenges and opportunities facing pathology services.

Alpha Laboratories has entered into a strategic partnership with Clinical Design Technologies to market and support that company's digital closed urine testing system. This innovative technology offers unmatched clinical efficacy, simplicity, and accuracy, setting a new standard for urinalysis at the point of care.

Roche has recently announced the completion of the acquisition of LumiraDx’s point-of-care technology, following the receipt of all required antitrust and regulatory clearances. Roche will now embark on the full integration of the company’s innovative multi-assay point of care platform and the related R&D, operational and commercial sites into its global organisation.

Scientists at the University of Warwick have made a breakthrough which could help find new treatments for a deadly infection that can affect up to 40% of hospital patients using mechanical ventilators.

New data from the UK Health Security Agency (UKHSA) highlights a rise in antibiotic-resistant gonorrhoea infections in England.

The latest issue of Pathology in Practice is now available to read online.

The Medical Research Council (MRC), in collaboration with the Biotechnology and Biological Sciences Research Council (BBSRC), has provided £28.5 million in funding to establish the Human Functional Genomics Initiative programme. It aims to advance our understanding of how genomic variation influences human physiology and how it changes over time and in disease.

Stago UK is introducing a unique autotransfusion system, able to preserve functional platelets as well as red blood cells. It offers a safer alternative to scarce, risky and expensive blood transfusion products. Stago UK has partnered with i-SEP, one of France’s most innovative MedTech companies, to distribute its novel ‘same’ system.

Paige, a global leader in clinical AI applications for cancer, in collaboration with Microsoft, has unveiled the second generation of Virchow, its million-slide foundation model for cancer.

Beckman Coulter Life Sciences, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, offers a promising new approach to oncology research delivering faster results with fewer touchpoints. The Illumina TruSight Oncology 500 DNA/RNA assay on the Biomek NGeniuS System from Beckman Coulter Life Sciences provides an automated solution enabling comprehensive genomic profiling of tumour samples.

MIP Discovery has announced the company’s rebrand to Tozaro, completing its transition to becoming a technology innovator in the cell and gene therapy (CGT) bioprocessing sector.

Fimlab Laboratories has selected Aiforia Technologies as the provider for breast and prostate cancer diagnostics solutions. Fimlab is Finland’s largest healthcare laboratory company, owned by the wellbeing services counties of Pirkanmaa, Central Finland, Kanta-Häme, Ostrobothnia, and Päijät-Häme.

Research published in the Journal of Parkinson's Disease shows promise for finding an objective, quantifiable, less-invasive biomarker for diagnosing Parkinson's disease.

National charity Group B Strep Support has produced a new free eLearning module on group B Streptococcus (GBS), to be used as a vital resource for midwives, doctors and health professionals in maternity services. It offers vital evidence-based education on GBS to enhance the care of pregnant women and people, and their babies, and ultimately will help save lives.